A concise profile of cervical cancer and its public health context
A QMUL-led Lancet study shows the HPV vaccine has dramatically reduced cervical cancer deaths among 20-24-year-olds in England from 2020–2024. England also sees an 80% fall in deaths in 2015–2019 for this age group. Yet uptake gaps threaten future gains as vaccination rates fall in parts of the country.
A round-up of recent cancer-related reports shows patients benefiting from clinical trials and rare misdiagnoses being corrected. From rectal cancer trials in the UK to cervical cancer misdiagnoses under review, readers are kept informed on treatment advances and patient experiences.
An international trial shows weekly HIV medication is as effective as daily doses, potentially reducing stigma and treatment burden. In Ghana, authorities reassure continued ARV availability amid distribution concerns. Nigerian and Ugandan health updates highlight high suppression rates and ongoing prevention efforts.
Two unvaccinated residents in Pennsylvania have died from measles, triggering a public health debate. Governor Shapiro says vaccinations could have averted the deaths, while RFK Jr. questions the figures, fueling a political row that experts warn could hinder responses to the outbreak.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
The NHS has launched a program to send self‑testing HPV kits to eligible women aged 30–65 who have missed cervical screening appointments. The at‑home swabs test for high‑risk HPV; negative results lead to in‑person follow‑ups. The phased rollout aims to boost screening uptake and support the 2040 elimination target.